Live Breaking News & Updates on அறிஞர் பாறை வைத்திருத்தல்
Stay updated with breaking news from அறிஞர் பாறை வைத்திருத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gainers OptiNose (NASDAQ:OPTN) stock rose 7.66% to $3.23 during Monday’s after-market session. Trading volume for this security closed at 10.4K, accounting for 2.73% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $171.5 million. Scholar Rock Holding (NASDAQ:SRRK) stock moved upwards by 6.76% to $28.57. At the close, Scholar Rock Holding’s trading volume reached 38.9K shares. This is 12.33% of its average volume over the last 100 days. The company’s market cap stands at $983.2 million. Bio-Path Holdings (NASDAQ:BPTH) stock increased by 5.35% to $5.9. Today’s trading volume for this security ended up closing at 268 shares, which is 0.04 percent of its average volume over the last 100 days. The company’s market cap stands at $41.0 million. ....
(AKU), APPLIED DNA SCIENCES (APDN) - 12 Health Care Stocks Moving In Monday's After-Market Session benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: BB BIOTECH AG / Key word(s): Annual Results/Dividend BB BIOTECH AG: Vaccines leading the way out of the pandemic - increased dividend of CHF 3.60 proposed 22.01.2021 / 07:00 Media release as of January 22, 2021 Portfolio of BB Biotech AG as of December 31, 2020 Vaccines leading the way out of the pandemic - increased dividend of CHF 3.60 proposed BB Biotech performed well in 2020 in a volatile market environment. The biotech sector made significant strides, leading the effort against the SARS-CoV-2 virus pandemic through approved mRNA vaccines and therapeutic antibodies. M&A activity picked up substantially in H2 2020, further driving solid performance as the year came to a close. The fourth quarter alone drove a portfolio gain of 20.6% in CHF, 20.4% in EUR and 25.5% in USD for BB Biotech - reflecting a net gain of CHF 665 mn. In parallel, the share price appreciated by 10.9% in CHF and 9.0% in EUR. BB Biotech exited four holdings and added ....
EQS-News: BB BIOTECH AG: Impfstoffe als Wegbereiter aus der COVID-19-Krise - | Newsticker fuw.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fuw.ch Daily Mail and Mail on Sunday newspapers.